Pharma Marketing Network Home

Pharma Marketing News is the monthly newsletter of the Pharma Marketing Network. It is distributed FREE to registered subscribers via email and the Web.

Subscribe



Editorial & Advisory Board
We accept advertising relevant to the interests of our subscribers.
For more information, see:

Media Kit





Published by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
Pharma Marketing News

Pharma Marketing News | Subscribe | Discussion Forums | Roundtable | Podcasts | Blog
Daily News Briefs | Surveys | Resources/Links | Glossary | Case Studies | Reports
Pharma Marketing Vendor Directory | Conference Calendar | Pharma Jobs
Advertising Information | FAQs | About Us | Privacy Policy


Disease Mongering: When Is the Line Crossed?

SUMMARY

Disease mongering is a term that was coined by the late journalist Lynn Payer to describe what she saw as the confluence of interests by some doctors, drug companies, patient advocacy groups and media in exaggerating the severity of illness and the ability of drugs to "cure" them. Some critics suggest that even pharma-sponsored disease awareness campaigns are forms of disease mongering. Pharma Marketing News recently hosted a live podcast interview of two experts in this area and this article summarizes this lively point-counterpoint discussion.

Topics and questions covered include:

  • Defining Disease Mongering
  • Is It a Legitimate Issue?
  • HCP Co-conspirators
  • Patient Advocate Co-conspirators
  • RLS Foundation's Ties to GSK
  • Does DTC Foster "Disease Mongering?"
  • Disease Awareness or Disease Mongering?
  • Effect on Industry Reputation
Order and pay for this reprint now using your credit card...

ONLY $2.95
Download PDF file immediately after paying:

Add to Cart

View Cart

PMN63-01
Issue: Vol. 6, No. 3: March 2007
Word Count: 3377

Find other articles in related Topic Areas:

Special Supplement
Direct-to-Consumer Advertising
Volume Two: DTC in the New Era

DTC Vol 2 Supplement Cover

This volume is devoted to DTC best practices with a focus on techniques for improving DTC efficacy and return on investment, which is generally considered to be declining.

TABLE OF CONTENTS

Order both Volume One and Volume Two and SAVE! (Click Here)

Order and pay for this Special Supplement (DTC Vol 2) now using your credit card...

ONLY $29.95
Download PDF file immediately after paying:

Add to Cart

View Cart

If you wish to be pay by check or credit card off-line, please use:
Printable Order Form




Pharma Marketing News | Subscribe | Discussion Forums | Roundtable | Podcasts | Blog
Daily News Briefs | Surveys | Resources/Links | Glossary | Case Studies | Reports
Pharma Marketing Vendor Directory | Conference Calendar | Pharma Jobs
Advertising Information | FAQs | About Us | Privacy Policy

© 2007. VirSci Corporation. All rights reserved.